To
understand the formation of lipid coronas around engineered
nanoparticles (NPs) in the blood, which may be produced by lipoproteins, i.e., the main lipid sources in the blood, we investigated
the biomolecular compositions of the hard coronas around PEGylated
Au NPs produced by high-density lipoproteins (HDLs). In this study,
we used mass spectrometric profiling to evaluate 19 representative
HDL lipids, the relative abundances of which were found to be altered
in the hard coronas compared with that in HDLs. In addition, the composition
of phospholipids (PLs) in the coronas did not show any dependence
on NP size, despite the evident size dependence in adsorbed HDL quantity.
These suggest that during the adsorption of whole HDL complexes on
the NPs, which prefer less curved NP surfaces, HDLs undergo disintegration
while their constituents coat the PEGylated surfaces of NPs. On the
other hand, neutral lipids, which are water-insoluble lipid cargo,
exhibited compositions that irregularly varied among experimental
batches. Their participation in the corona formation is attributed
to hydrophobicity rather than explicit interaction with the PEGylated
surfaces. Among them, free cholesterol (Chol) was remarkably enriched
in the coronas, which was 20–100 times larger than that of
other lipids and apolipoprotein A1. Considering that Chol is an important
structural component in cellular membranes, its noticeable enrichment
may suggest its possible involvement in the structures of lipid coronas
through interactions with neighboring PLs, of which excess accumulation
may play a critical role in the pathogenesis of multiple diseases.
The elucidated features of HDL coronas were found to be reflected
in the lipid coronas produced in the human serum as well. This understanding
of biomolecular coronas produced by HDL complexes would provide further
insights to investigate their biological impacts beyond protein coronas
for designing future nanomedicines.